Cite

HARVARD Citation

    Tamjid, B. et al. (n.d.). 3218 PACEBOM in relapsed/refractory (R/R) lymphoma in the rituximab (R) era. European journal of cancer. pp. S655-. [Online]. 
  
Back to record